Back to Search Start Over

The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans.

Authors :
Chávez-Sánchez L
Garza-Reyes MG
Espinosa-Luna JE
Chávez-Rueda K
Legorreta-Haquet MV
Blanco-Favela F
Source :
Human immunology [Hum Immunol] 2014 Apr; Vol. 75 (4), pp. 322-9. Date of Electronic Publication: 2014 Jan 30.
Publication Year :
2014

Abstract

Unlabelled: Toll-like receptor (TLR)2, TLR4 and CD36 are central in inflammation and the development of atherosclerosis. Oxidized low-density lipoprotein (oxLDL) plays a critical role in this disease through its involvement in the formation of foam cells and the activation of leukocytes. The aim of this research was to analyze the role of TLR2, TLR4 and CD36 in foam cell differentiation and macrophage activation.<br />Methods: Human macrophages were incubated with monoclonal antibodies specific for TLR2, TLR4 and CD36 prior to stimulation with oxLDL. Subsequently, we analyzed foam cell formation, cytokine secretion, histocompatibility complex (MHC) class II molecules and CD86 expression and T cell proliferation.<br />Results: The stimulation of macrophages with oxLDL induced foam cell formation, cytokine secretion, HLA-DR and CD86 expression and T cell proliferation. The blockage of TLR2, TLR4 and CD36 reduced the secretion of IL-1β, IL-6 and IL-8, the expression of HLA-DR and CD86, T cell proliferation and foam cell formation. However, the blockage of TLR2 did not affect the formation of foam cells.<br />Conclusion: Our study demonstrates that TLR2, TLR4 and CD36 participate in the immune response to oxLDL by inducing an increase in pro-inflammatory cytokines, the expression HLA-DR and CD86 and the proliferation of T cells. However, TLR2 does not participate in the formation of foam cells, while TLR4 and CD36 play a relevant role in this process. These findings suggest that the activation of these receptors by oxLDL contributes to the pathogenesis of atherosclerosis.<br /> (Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-1166
Volume :
75
Issue :
4
Database :
MEDLINE
Journal :
Human immunology
Publication Type :
Academic Journal
Accession number :
24486576
Full Text :
https://doi.org/10.1016/j.humimm.2014.01.012